Vernal

Vernal is a Vermont-based biotechnology company that develops and commercializes vaccines and gene editing for the treatment of cancer.

Business Model:

Revenue: $2.1M

Employees: 51-200

Rankings

Detailed Vernal Information

Geographic Data

Vernal headquarters map

Address: 4582 Stowe Hollow Road

City: Stowe

State: VT

Zip: 05672

Country: US

Financial Info

Stage:

series a

Raised Last:

$20M

Raised Total:

$21M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Vernal is a Vermont-based biotechnology company that develops and commercializes vaccines and gene editing for the treatment of cancer.

Contact Phone:
+15127919680

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2022 Series A $0 Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
6/2022 Venture Round $0 Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
6/2023 Series A $0 Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
7/2021 Seed Round 2 - Alloy Therapeutics
Vermont Center for Emerging Technologies
Alloy Therapeutics
Vermont Center for Emerging Technologies
7/2021 Seed -
5/2022 Equity $21M Ampersand Capital Partners
Dynamk Capital
Alloy Therapeutics
ATUM
Charles River Laboratories, Inc
7/2021 Seed - Alloy Therapeutics
Vermont Center for Emerging Technologies
Alloy Therapeutics
Vermont Center for Emerging Technologies
6/2023 Series A 4 $20M Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
Ampersand Capital Partners
Charles River Laboratories International
Dynamk Capital
Vermont Center for Emerging Technologies
6/2022 Series A 5 $21M Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
Alloy Therapeutics
Ampersand Capital Partners
ATUM
Charles River Laboratories International
Dynamk Capital
7/2021 Seed Round 2 - Alloy Therapeutics
Vermont Center for Emerging Technologies
Alloy Therapeutics
Vermont Center for Emerging Technologies
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research